CD79A and COVID-19: Using a recently described S-Fuse assay18, we detected neutralizing antibodies in 13 of 17 ‘naso-positive’ patients with COVID-19 (76%) that increased with disease severity and strongly correlated with the presence of spike-specific IgA and IgG (Fig. 1j–l).